As part of its effort to encourage rigorous collaborative international research, the NIDA International Program has issued a Program Announcement soliciting proposals for International Research Collaboration on Drug Abuse and Addiction Research to support projects that:
- Take advantage of unusual opportunities that exist outside the United States to access talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery
- Describe how the research will significantly advance U.S. health sciences
- Demonstrate specific relevance to the NIDA mission and objectives. To determine whether your research plan is relevant to the NIDA mission and objectives, review the NIDA Strategic Plan. Where feasible, applications should address NIDA’s international scientific priority areas.
- Include an investigator from a U.S. institution and a non-U.S. citizen partner living and working in another country.
This is a broad call for innovative research, and applications are encouraged in all areas of science addressing drug addiction including but not limited to prevention, basic science, epidemiology, treatment, and health services. Specific application requirements are available online:
Individuals who wish to use a different grant mechanism are encouraged to apply for funding using one of the following already published "parent" funding opportunity announcements:
- R03 NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) PA-18-488
- R21 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) PA-18-489
- R21 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) PA-18-344
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Administrative Supplement Clinical Trial Optional) PA-18-591